HopeStage
Back to all studies
RecruitingNCT04946916

Blood markers to distinguish cognitive problems in psychiatric and brain diseases

About this titleRead the official source — NCT04946916
Study assessmentsAges 45–80FranceSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 45 years to 80 years.

Listed locations
Bron and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 22, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
Hôpital le Vinatier
Sponsor type
Hospital / academic medical center
Study type
Diagnostic Test
Intervention type
Diagnostic test
Locations
France
Age range
From 45 Years to 80 Years
Official registry ID
NCT04946916
Official title
Show the full official title

Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases

Recruitment & locations

Currently recruiting

Bron

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hôpital le Vinatier, a hospital or academic medical center.

Who can participate?

Listed age limits: 45 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies